Publication

Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer

Journal Paper/Review - Jun 20, 2013

Jonat W, Bachelot T, Ruhstaller Thomas, Kuss I, Reimann U, Robertson J F R